Cyteir Therapeutics

Through a unique cancer treatment approach, Cyteir Therapeutics is creating breakthrough solutions to the major challenges facing cancer researchers today. Currently in development, is the answer to the oncology triumvirate: reducing side effects, reducing therapy resistance, inducing diseased cell... Read more

Industries

Stage

IPO

Employees

11-50

Links

Org chart

Markus Renschler
President & CEO
Collapse
David Gaiero
Chief Financial Officer
Adam Veness
General Counsel
Krisztina Nemenyi
SVP, Regulatory Affairs & Quality
Tom O'Shea
SVP, Clinical Pharmacology & Preclinical Development
Susan Doleman
VP, Clinical Operations
Jean-Marc Lapierre
VP, Chemistry
Two candidates
The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.